St. Denis J. Villere & Co’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1M Buy
574,968
+70,613
+14% +$1.88M 1.78% 35
2025
Q4
$12.6M Buy
504,355
+345,820
+218% +$8.72M 1.26% 38
2025
Q3
$4.04M Buy
158,535
+14,575
+10% +$360K 0.39% 39
2025
Q2
$3.49M Sell
143,960
-6,460
-4% -$151K 0.34% 38
2025
Q1
$3.81M Sell
150,420
-49
-0% -$1.28K 0.37% 38
2024
Q4
$3.99M Sell
150,469
-23,144
-13% -$628K 0.36% 42
2024
Q3
$5.02M Sell
173,613
-11,670
-6% -$340K 0.41% 41
2024
Q2
$5.18M Sell
185,283
-1,715
-0.9% -$47.2K 0.44% 42
2024
Q1
$5.19M Sell
186,998
-10,565
-5% -$293K 0.41% 40
2023
Q4
$5.69M Sell
197,563
-13,054
-6% -$395K 0.47% 40
2023
Q3
$6.99M Buy
210,617
+1,976
+0.9% +$69.9K 0.6% 41
2023
Q2
$7.65M Buy
208,641
+1,126
+0.5% +$43.8K 0.55% 42
2023
Q1
$8.47M Sell
207,515
-33,708
-14% -$1.46M 0.62% 41
2022
Q4
$12.4M Sell
241,223
-6,275
-3% -$301K 0.96% 35
2022
Q3
$10.8M Buy
247,498
+10,955
+5% +$532K 0.86% 38
2022
Q2
$12.4M Sell
236,543
-3,241
-1% -$165K 0.93% 35
2022
Q1
$12.4M Sell
239,784
-10,866
-4% -$564K 0.74% 34
2021
Q4
$14.8M Sell
250,650
-1,135
-0.5% -$56.2K 0.85% 34
2021
Q3
$10.8M Buy
251,785
+415
+0.2% +$18.4K 0.63% 35
2021
Q2
$9.84M Buy
251,370
+6,110
+2% +$238K 0.53% 35
2021
Q1
$8.88M Buy
245,260
+42,395
+21% +$1.51M 0.49% 35
2020
Q4
$7.47M Buy
202,865
+40,849
+25% +$1.5M 0.45% 35
2020
Q3
$5.64M Buy
+162,016
New +$5.68M 0.38% 39

Other funds holding PFE

St. Denis J. Villere & Co's PFE Position: Q1 2026 in Review

St. Denis J. Villere & Co increased its Pfizer (PFE) stake by 14% in Q1 2026, buying an estimated $1.88M and bringing the position to 574,968 shares worth $16.1M. The position accounts for 1.78% of the portfolio, ranked #35.

St. Denis J. Villere & Co first reported a position in PFE in Q3 2020 and has held it in 23 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • St. Denis J. Villere & Co held 574,968 shares of Pfizer worth $16.1M as of Q1 2026.
  • St. Denis J. Villere & Co bought 70,613 Pfizer shares in Q1 2026, an estimated $1.88M.
  • Pfizer made up 1.78% of St. Denis J. Villere & Co's portfolio in Q1 2026, its #35 holding.
  • St. Denis J. Villere & Co first reported a position in Pfizer in Q3 2020 and has held it in 23 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on St. Denis J. Villere & Co's 13F filing for Q1 2026, filed 30 Apr 2026.